inveJoin CCC on Wednesday, 28 September 2022 at 11:00am EDT / 5:00pm CEST for a unique panel discussion with Eli Lilly and Company’s Legal and Library teams on how they partner to accelerate the innovation of new medicines, improve patient outcomes, and promote global compliance.
Lilly strives to not only create high-quality medicines, but also ensure that the benefits and risks of medications are continuously monitored and well-understood by regulators, health care professionals and patients.
Learn how they rely on access to the latest information and scientific literature to support that mission, and are committed to making sure that employees are accessing and reusing content compliantly. Regardless of your industry, this session will serve as a model for anyone involved with managing information and copyright throughout the organization.
 |
 |
 |
 |
Christina Bennett McNew,Associate Director, Library Operations, Eli Lilly and Company |
John Rudolph, Ph.D., LL.B.Associate Vice President and Assistant General Counsel, Trademarks,Eli Lilly and Company |
Bruce LongbottomAssociate Vice President and Assistant General Counsel, Trademarks,Eli Lilly and Company |
Stephen Casbeer,Sr. Strategic Client Engagement |